Harvard Bioscience, Inc. vs Milestone Scientific Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Harvard Bioscience, Inc. is the larger company by market value: $38 M against $31 M for Milestone Scientific Inc., 1.2 times as much (market caps of Oct 26, 2026 for Harvard Bioscience, Inc. and Oct 14, 2026 for Milestone Scientific Inc.).
- Harvard Bioscience, Inc. had more revenue: $87 M against $9 M for Milestone Scientific Inc., both in the year to December 2025.
- Both made a net loss: $57 M for Harvard Bioscience, Inc. and $6 M for Milestone Scientific Inc.
- Milestone Scientific Inc. keeps more of each dollar of sales: a net margin of -63.8% against -65.5% for Harvard Bioscience, Inc.
- Milestone Scientific Inc.'s revenue grew faster in its latest fiscal year: +3.9% against -8.1% for Harvard Bioscience, Inc.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Harvard Bioscience, Inc. HBIO · #22,291 in the world | Milestone Scientific Inc. MLSS · #22,991 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments | Medical Instruments |
| Founded | 1901 | — |
| Size | ||
| Market cap | $38 M | $31 M |
| Revenue | $87 M | $9 M |
| Net income | $-57 M | $-6 M▲ best |
| Employees | — | 15 |
| Valuation | ||
| Price to sales | 0.4× | 3.3× |
| Price to book | 2.7× | 11.0× |
| Free cash flow yield | 14.5%▲ best | -9.5% |
| Profitability | ||
| Gross margin | 57.7% | 71.5%▲ best |
| Operating margin | -56.1%▲ best | -63.5% |
| Net margin | -65.5% | -63.8%▲ best |
| Return on equity | -147.1% | -132.4%▲ best |
| Growth | ||
| Revenue growth | -8.1% | 3.9%▲ best |
| Revenue growth, 3 years a year | -8.6% | 0.6%▲ best |
| Financial strength | ||
| Debt to equity | 2.6× | — |
| Interest cover | -37.4× | — |
| Cash | ||
| Free cash flow margin | 6.3%▲ best | -32.8% |
| Strength scores | ||
| Piotroski F-score | 5 of 9 | — |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Harvard Bioscience, Inc. or Milestone Scientific Inc.?
Harvard Bioscience, Inc. is the larger company by market value: $38 M against $31 M for Milestone Scientific Inc., 1.2 times as much (market caps of Oct 26, 2026 for Harvard Bioscience, Inc. and Oct 14, 2026 for Milestone Scientific Inc.).
Which makes more money, Harvard Bioscience, Inc. or Milestone Scientific Inc.?
Harvard Bioscience, Inc. had more revenue: $87 M against $9 M for Milestone Scientific Inc., both in the year to December 2025. Both made a net loss: $57 M for Harvard Bioscience, Inc. and $6 M for Milestone Scientific Inc.
Which is more profitable, Harvard Bioscience, Inc. or Milestone Scientific Inc.?
Milestone Scientific Inc. keeps more of each dollar of sales: a net margin of -63.8% against -65.5% for Harvard Bioscience, Inc.
Which is growing faster, Harvard Bioscience, Inc. or Milestone Scientific Inc.?
Milestone Scientific Inc.'s revenue grew faster in its latest fiscal year: +3.9% against -8.1% for Harvard Bioscience, Inc.
Which is financially stronger, Harvard Bioscience, Inc. or Milestone Scientific Inc.?
Both are in the distress zone of the Altman Z-score.
More about Harvard Bioscience, Inc.
More about Milestone Scientific Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.